Does concomitant ductal carcinoma in situ influence the prognostic outcome after neoadjuvant therapy in triple-negative invasive ductal carcinoma?
The presence of DCIS component in patients with triple-negative IDC is associated with lower tumor aggressiveness and improved DFS after NAT compared to patients without DCIS. Additionally, clinical T and N stages are risk factors for residual DCIS after NAT in patients with triple-negative IDC and a DCIS component.
Authors
- Zehao Huang (ORCID: https://orcid.org/0000-0003-1653-208X)
- Yue Teng (ORCID: https://orcid.org/0000-0002-5635-3206)
- Wei Xing (ORCID: https://orcid.org/0000-0003-2841-7206)
- Li Liang (ORCID: https://orcid.org/0000-0001-5302-2754)
- Sicheng Zhou (ORCID: https://orcid.org/0000-0003-0420-2892)
Institutions
- Peking University (CN)
- Hebei University of Chinese Medicine (CN)
- Peking University First Hospital (CN)
- Affiliated Hospital of Hebei University (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1186/s12957-025-03753-x
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00